BAMFORD PASCAL — SEC Form 4 filings

SEC reporting owner CIK 2035474. 5 Form 4 filings on record with FilingPulse; latest filed 2025-07-10.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-09-03 to 2025-07-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Akoya Biosciences, Inc. (AKYA)Chief Clinical Officer511

Form 4 filings — BAMFORD PASCAL

FiledFormIssuerReported transactionsSource
2025-07-104Akoya Biosciences, Inc. (AKYA)Other (J): 9,488 · Other (J): 196,250 · Other (J): 150,000 (derivative) @ $0 · Other (J): 25,000 (derivative) @ $0 · Other (J): 15,000 (derivative) @ $0 · Other (J): 50,000 (derivative) @ $0EDGAR
2025-06-024Akoya Biosciences, Inc. (AKYA)Tax withholding (F): 670 @ $1.25EDGAR
2025-03-044Akoya Biosciences, Inc. (AKYA)Tax withholding (F): 1,283 @ $1.63 · Tax withholding (F): 2,567 @ $1.63EDGAR
2024-11-214Akoya Biosciences, Inc. (AKYA)Grant/award (A): 87,500 @ $0EDGAR
2024-09-034Akoya Biosciences, Inc. (AKYA)Grant/award (A): 40,000 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2035474 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →